IL107838A0 - Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing them - Google Patents
Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL107838A0 IL107838A0 IL10783893A IL10783893A IL107838A0 IL 107838 A0 IL107838 A0 IL 107838A0 IL 10783893 A IL10783893 A IL 10783893A IL 10783893 A IL10783893 A IL 10783893A IL 107838 A0 IL107838 A0 IL 107838A0
- Authority
- IL
- Israel
- Prior art keywords
- antagonists
- preparation
- pharmaceutical compositions
- compositions containing
- compounds useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929225396A GB9225396D0 (en) | 1992-12-04 | 1992-12-04 | Improvements in or relating to organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL107838A0 true IL107838A0 (en) | 1994-04-12 |
Family
ID=10726140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10783893A IL107838A0 (en) | 1992-12-04 | 1993-12-02 | Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing them |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0606044A1 (fi) |
JP (1) | JPH06228122A (fi) |
KR (1) | KR940014377A (fi) |
CN (1) | CN1095417A (fi) |
AU (1) | AU5211293A (fi) |
CA (1) | CA2110553A1 (fi) |
CZ (1) | CZ261493A3 (fi) |
FI (1) | FI935409A (fi) |
GB (1) | GB9225396D0 (fi) |
HU (1) | HUT65910A (fi) |
IL (1) | IL107838A0 (fi) |
MX (1) | MX9307608A (fi) |
NO (1) | NO934372L (fi) |
NZ (1) | NZ250344A (fi) |
PL (1) | PL301281A1 (fi) |
SK (1) | SK135493A3 (fi) |
TW (1) | TW258736B (fi) |
ZA (1) | ZA939088B (fi) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4228328C2 (de) * | 1992-08-26 | 1999-02-11 | Agie Sa | Maschine und Verfahren zum funkenerosiven Drahtschneiden mit einer im Querschnitt verformten Drahtelektrode |
US5795910A (en) * | 1994-10-28 | 1998-08-18 | Cor Therapeutics, Inc. | Method and compositions for inhibiting protein kinases |
US5731343A (en) * | 1995-02-24 | 1998-03-24 | The Scripps Research Institute | Method of use of radicicol for treatment of immunopathological disorders |
EP0823429B1 (en) * | 1995-04-26 | 2000-07-12 | Kyowa Hakko Kogyo Co., Ltd. | Radicicol derivatives |
AU779438B2 (en) * | 1998-12-24 | 2005-01-27 | Novation Pharmaceuticals Inc. | Compounds which affect mRNA stability and uses therefor |
ATE328888T1 (de) | 2000-08-25 | 2006-06-15 | Sloan Kettering Inst Cancer | Radicicol und monocillin und ihre analogen und ihre anwendungen |
JP2004292314A (ja) * | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | ケラチノサイト増殖抑制剤 |
JP2004292315A (ja) * | 2000-12-14 | 2004-10-21 | Chugai Pharmaceut Co Ltd | Tak1阻害剤 |
GB0112522D0 (en) * | 2001-05-23 | 2001-07-11 | Ici Plc | Catalytic process |
PL221491B1 (pl) | 2002-03-08 | 2016-04-29 | Eisai R&D Man Co | Związki makrocykliczne, środek farmaceutyczny zawierający te związki oraz zastosowanie tych związków |
US7915306B2 (en) * | 2002-03-08 | 2011-03-29 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
CA2482940A1 (en) * | 2002-04-17 | 2003-10-23 | Taisho Pharmaceuticals Co., Ltd. | Hair growth tonic |
WO2006036941A2 (en) * | 2004-09-27 | 2006-04-06 | Kosan Biosciences Incorporated | Specific kinase inhibitors |
US7601852B2 (en) | 2006-05-11 | 2009-10-13 | Kosan Biosciences Incorporated | Macrocyclic kinase inhibitors |
JP5484327B2 (ja) | 2007-07-25 | 2014-05-07 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 癌の処置において使用するための多キナーゼインヒビター |
EP2215471B1 (en) | 2007-10-29 | 2012-02-08 | Eisai R&D Management Co., Ltd. | Methods for prognosing the ability of a zearalenone analog compound to treat cancer |
WO2009075823A1 (en) | 2007-12-07 | 2009-06-18 | Eisai R & D Management Co., Ltd. | Intermediates in the synthesis of zearalenone macrolide analogs |
WO2010045342A1 (en) | 2008-10-17 | 2010-04-22 | Wisconsin Alumni Research Foundation | Method of making biologically active alpha-beta peptides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3196019A (en) * | 1964-04-06 | 1965-07-20 | Purdue Research Foundation | Anabolic and estrogenic compound and process of making |
-
1992
- 1992-12-04 GB GB929225396A patent/GB9225396D0/en active Pending
-
1993
- 1993-11-29 EP EP93810835A patent/EP0606044A1/en not_active Withdrawn
- 1993-12-02 AU AU52112/93A patent/AU5211293A/en not_active Abandoned
- 1993-12-02 NO NO934372A patent/NO934372L/no unknown
- 1993-12-02 IL IL10783893A patent/IL107838A0/xx unknown
- 1993-12-02 NZ NZ250344A patent/NZ250344A/en unknown
- 1993-12-02 MX MX9307608A patent/MX9307608A/es unknown
- 1993-12-02 FI FI935409A patent/FI935409A/fi not_active Application Discontinuation
- 1993-12-02 CA CA002110553A patent/CA2110553A1/en not_active Abandoned
- 1993-12-02 PL PL93301281A patent/PL301281A1/xx unknown
- 1993-12-02 CZ CZ932614A patent/CZ261493A3/cs unknown
- 1993-12-02 SK SK1354-93A patent/SK135493A3/sk unknown
- 1993-12-03 JP JP5303866A patent/JPH06228122A/ja active Pending
- 1993-12-03 ZA ZA939088A patent/ZA939088B/xx unknown
- 1993-12-03 HU HU9303444A patent/HUT65910A/hu unknown
- 1993-12-03 CN CN93120777A patent/CN1095417A/zh active Pending
- 1993-12-03 KR KR1019930026567A patent/KR940014377A/ko not_active Application Discontinuation
- 1993-12-06 TW TW082110279A patent/TW258736B/zh active
Also Published As
Publication number | Publication date |
---|---|
EP0606044A1 (en) | 1994-07-13 |
NO934372D0 (no) | 1993-12-02 |
CZ261493A3 (en) | 1994-07-13 |
HUT65910A (en) | 1994-07-28 |
KR940014377A (ko) | 1994-07-18 |
GB9225396D0 (en) | 1993-01-27 |
NZ250344A (en) | 1995-10-26 |
PL301281A1 (en) | 1994-06-13 |
CN1095417A (zh) | 1994-11-23 |
NO934372L (no) | 1994-06-06 |
JPH06228122A (ja) | 1994-08-16 |
TW258736B (fi) | 1995-10-01 |
MX9307608A (es) | 1995-01-31 |
AU5211293A (en) | 1994-06-16 |
ZA939088B (en) | 1995-06-05 |
FI935409A (fi) | 1994-06-05 |
CA2110553A1 (en) | 1994-06-05 |
FI935409A0 (fi) | 1993-12-02 |
SK135493A3 (en) | 1994-08-10 |
HU9303444D0 (en) | 1994-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL107838A0 (en) | Compounds useful as cytokine release inhibitors and il-1 antagonists, their preparation and pharmaceutical compositions containing them | |
IL111627A0 (en) | Substituted phenylpyrimidine compounds, their preparation and pharmaceutical compositions containing them | |
HUT66324A (en) | Quinazoline derivatives as acetylcholinesterase inhibitors and pharmaceutical compositions containing them | |
IL102638A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
IL103053A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
IL106353A0 (en) | Unsymmetrical mono-3-nitro-bis-naphthalimides,their preparation and pharmaceutical compositions containing them | |
HUT70544A (en) | Heteroaryl-amines as acetyl-cholinesterase inhibitors, pharmaceutical compositions comprising them and process for their preparation | |
IL101380A0 (en) | Bis-naphthalimides,their preparation and pharmaceutical compositions containing them | |
HUP0000678A3 (en) | Aminobenzophenones as inhibitors of interleukin and tnf, process for their preparation and pharmaceutical compositions containing the same | |
IL103757A (en) | Oligodeoxyribonucleotides their preparation and pharmaceutical compositions containing them | |
HUP9900071A3 (en) | Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use | |
EP0499416A3 (en) | Pyridine compounds as angiotensin ii antagonists, processes for their preparation and pharmaceutical compositions containing them | |
IL108073A0 (en) | Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them | |
IL104099A0 (en) | Imidazoquinazoline compounds,their preparation and pharmaceutical compositions containing them | |
IL106408A0 (en) | Benzimidazoles,their preparation and pharmaceutical compositions containing them | |
IL105356A0 (en) | Benzimidazoles,their preparation and pharmaceutical compositions containing them | |
IL106385A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
IL87600A0 (en) | Hmg-coa reductase inhibitors,their preparation and pharmaceutical compositions containing them | |
IL104042A0 (en) | Substituted diphenylsulfides,their preparation and pharmaceutical compositions containing them | |
IL106041A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
IL105774A0 (en) | Thienothiazine derivatives,their preparation and pharmaceutical compositions containing them | |
IL89155A0 (en) | Ouabain-like compounds and pharmaceutical compositions containing them | |
IL104347A0 (en) | Substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them | |
IL101164A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
IL105370A0 (en) | Propenoyl-imidazole derivatives,their preparation and pharmaceutical compositions containing them |